We’re one of the only clinics in the United States offering stem cell therapies that has a research department and uses a registry to track patients and publish the results of our patients. To that end, we just published another study as a safety update for Regenexx-C stem cell therapy as well as knee outcome data for severe knee arthritis patients. This complication study tracked 339 patients for up to 4 years (our last study looked at 227 patients for 2-3 years) and involved over 200 research grade MRI’s of 50 patients to ensure that the cultured stem cells had produced no problems. In addition, this new study publishes additional knee data showing very good results when all patients are factored in (not just the patients that did well with stem cell therapy, but also the patients that didn’t respond). We’re proud of our Regenexx stem cell research and our commitment to research the Regenexx family of procedures.
About the Author
Christopher J. Centeno, M.D. is an international expert and specialist in regenerative medicine and the clinical use of mesenchymal stem cells in orthopedics. He is board certified in physical medicine as well as rehabilitation and in pain management through The American Board of Physical Medicine and Rehabilitation.…